. Author manuscript; available in PMC: 2014 Sep 12.

Published in final edited form as: Gynecol Oncol. 2009 Oct 17;116(1):61–65. doi: 10.1016/j.ygyno.2009.09.018

Table 4.

Number of extreme drug resistance and chemotherapy response

No. of EDR	Cases	Response
0	63 (28.5%)	80.9%
1	60 (27.1%)	80.0%
2	40 (18.1%)	82.5%
3	35 (15.8%)	88.6%
4	13 (5.9%)	69.2%
5	7 (3.2%)	85.7%
6	3 (1.4%)	100%

Among the 227 patients who received postoperative chemotherapy treatment, 225 patients received combination chemotherapy with platinum and taxane. Four patients developed allergic reaction to taxane and in total 221 patients were available for chemotherapy response. Fisher’s exact test. P=0.76.